Telapine 40/10 mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Austin Pharmaceutical Co., Ltd.
MFDS item code 202000464 · Approved 2020.01.29
This product's status changed to Expired on 2025.01.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled by monotherapy
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of telmisartan or amlodipine. Essential hypertension is a condition where high blood pressure imposes burden on the heart and blood vessels. This medicine effectively lowers the blood pressure, protects the cardiovascular system, and reduces the risk of complications. Therefore, it is prescribed to aid in the control of hypertension, leading to stable improvements in blood pressure.
The recommended dose of this medicine is 1 tablet once daily, taken with water with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the doses of the individual components (telmisartan or amlodipine) be adjusted before starting this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring careful administration’.) In elderly patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
○ Pediatric patients aged 18 years and younger: Administration of this medicine is not recommended because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, and therefore should not be taken by pregnant women or women who may become pregnant. Additionally, it should not be administered to patients who are allergic to any of its components, those with severe liver or heart dysfunction, hypotensive patients, patients in cardiogenic shock, or those with unstable heart failure following acute myocardial infarction. Particular caution is required for patients with compromised liver function, obstructive biliary disease, cardiac valve diseases, gastrointestinal disorders, or renal vascular diseases when using this medication. Common side effects such as dizziness or peripheral edema may occur when taking this medication, and in severe cases, fainting may occur, so consult a healthcare professional immediately if symptoms are severe. The use of this medication should be avoided during pregnancy, and once pregnancy is confirmed, discontinuation should occur as soon as possible and replaced with safer treatment options. Given that this medication lowers blood pressure, hypotensive patients should consult a physician before taking it, and blood pressure changes should be monitored closely during treatment. The medication may increase blood potassium levels; therefore, patients at risk of hyperkalemia should undergo regular blood tests. Patients with compromised renal function may experience worsened kidney function due to this medication, necessitating periodic kidney function tests. This medication can interact with other drugs, so if currently taking other medications, be sure to inform your physician or pharmacist, especially when used in conjunction with diuretics, lithium, warfarin, or grapefruit juice. Breastfeeding women are advised not to take this medication, and caution should be exercised when driving or operating machinery as dizziness or drowsiness may occur. In case of overdose, severe hypotension, dizziness, or acute kidney failure may occur, necessitating immediate medical attention and appropriate emergency treatment. This medication has not been sufficiently confirmed for safety and efficacy in children, and therefore, its use is not recommended. Lastly, this medication should be stored out of reach of children, in its original packaging, and opened just before use.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light and should be stored in a container that blocks light. Additionally, to maintain the effectiveness of the medicine, it is important to store it at room temperature, between 1 to 30 degrees Celsius.
White and light blue biconvex oval double-coated tablet
30 tablets/box [10 tablets/PTP × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Austin Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.